Clinical trial
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like Particles (VLP) Quadrivalent Influenza Vaccine in the Elderly Population
NCT02236052 is registered in ClinicalTrials.gov with Medicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like Particles (VLP) Quadrivalent Influenza Vaccine in the Elderly Population
- Lead sponsor
- Medicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 16, 2014
- Completion date
- June 17, 2015
- Enrollment
- 450 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.